Alnylam Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CAPITAL WORLD INVESTORS | 05/12/2025 | 16.75 M | $4.52 B | 0.90% | 12.92% |
| FMR LLC | 05/12/2025 | 15.31 M | $4.13 B | 13.52% | 11.81% |
| VANGUARD GROUP INC | 05/09/2025 | 13.06 M | $3.53 B | 2.54% | 10.07% |
| BLACKROCK, INC. | 05/02/2025 | 9.56 M | $2.58 B | -3.30% | 7.37% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 05/12/2025 | 7.15 M | $1.93 B | 2.67% | 5.52% |
| REGENERON PHARMACEUTICALS, INC. | 05/02/2025 | 4.44 M | $1.20 B | 0.00% | 3.43% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/14/2025 | 4.42 M | $1.19 B | 0.77% | 3.41% |
| BAILLIE GIFFORD & CO | 05/07/2025 | 3.66 M | $987.63 M | -9.47% | 2.82% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 3.51 M | $946.47 M | 5.60% | 2.70% |
| STATE STREET CORP | 05/15/2025 | 3.37 M | $909.04 M | -1.64% | 2.60% |
| DODGE & COX | 05/14/2025 | 3.35 M | $905.04 M | -5.32% | 2.58% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 2.61 M | $705.02 M | -37.78% | 2.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 2.32 M | $625.82 M | 5.26% | 1.79% |
| JPMORGAN CHASE & CO | 05/12/2025 | 2.22 M | $599.14 M | -1.39% | 1.71% |
| AMERICAN CENTURY COMPANIES INC | 05/13/2025 | 1.76 M | $475.35 M | 9.75% | 1.36% |
| ORBIS ALLAN GRAY LTD | 05/15/2025 | 1.63 M | $441.46 M | 11.01% | 1.26% |
| GROUPAMA ASSET MANAGMENT | 05/14/2025 | 1.54 M | $12.51 M | 0.76% | 1.19% |
| WINSLOW CAPITAL MANAGEMENT, LLC | 05/14/2025 | 1.19 M | $320.56 M | 16.33% | 0.92% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 1.06 M | $287.46 M | 154.35% | 0.82% |
| INVESCO LTD. | 05/12/2025 | 913.79 K | $246.74 M | 63.62% | 0.70% |
| 05/12/2025 | 883.37 K | $148.75 M | 100.00% | 0.68% | |
| LEGAL & GENERAL GROUP PLC | 05/15/2025 | 881.11 K | $237.92 M | 6.30% | 0.68% |
| NORTHERN TRUST CORP | 05/13/2025 | 865.02 K | $233.57 M | -1.57% | 0.67% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 828.34 K | $217.03 M | 1.84% | 0.64% |
| BELLEVUE GROUP AG | 05/14/2025 | 768.15 K | $207.42 M | -0.28% | 0.59% |
| UBS ASSET MANAGEMENT AMERICAS INC | 05/19/2025 | 736.11 K | $198.76 M | 3.59% | 0.57% |
| MORGAN STANLEY | 05/15/2025 | 641.77 K | $173.29 M | -11.75% | 0.49% |
| DEUTSCHE BANK AG\ | 05/09/2025 | 576.99 K | $155.80 M | 3.67% | 0.44% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 554.61 K | $149.75 M | 7.91% | 0.43% |
| LOOMIS SAYLES & CO L P | 05/14/2025 | 497.48 K | $134.33 M | -1.11% | 0.38% |
| TD ASSET MANAGEMENT INC | 05/07/2025 | 486.58 K | $131.39 M | -3.46% | 0.38% |
| PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 480.97 K | $129.70 M | 11.69% | 0.37% |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 474.83 K | $128.21 M | -0.91% | 0.37% |
| FRANKLIN RESOURCES INC | 05/13/2025 | 458.31 K | $123.75 M | 10.67% | 0.35% |
| AMUNDI | 05/15/2025 | 455.00 K | $119.28 M | -8.32% | 0.35% |
| GOLDMAN SACHS GROUP INC | 05/16/2025 | 423.37 K | $114.32 M | 38.15% | 0.33% |
| SWISS NATIONAL BANK | 05/12/2025 | 364.20 K | $98.34 M | 0.44% | 0.28% |
| ORBIMED ADVISORS LLC | 05/15/2025 | 346.10 K | $93.45 M | -16.72% | 0.27% |
| GILDER GAGNON HOWE & CO LLC | 05/15/2025 | 345.58 K | $93.31 M | -5.44% | 0.27% |
| ROYAL BANK OF CANADA | 05/15/2025 | 337.23 K | $91.06 M | 8.72% | 0.26% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 330.35 K | $89.20 M | -31.92% | 0.25% |
| DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 309.82 K | $83.64 M | -7.15% | 0.24% |
| JENNISON ASSOCIATES LLC | 05/05/2025 | 309.22 K | $83.50 M | 18.97% | 0.24% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2025 | 300.64 K | $81.18 M | 100.00% | 0.23% |
| WELLS FARGO & COMPANY/MN | 05/13/2025 | 300.08 K | $81.03 M | 8.35% | 0.23% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 04/25/2025 | 291.48 K | $78.70 M | 1.66% | 0.22% |
| D. E. SHAW & CO., INC. | 05/15/2025 | 289.86 K | $78.27 M | -20.17% | 0.22% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 287.34 K | $77.59 M | -13.83% | 0.22% |
| ROYAL LONDON ASSET MANAGEMENT LTD | 05/13/2025 | 286.94 K | $77.48 M | 1.93% | 0.22% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 282.18 K | $76.20 M | 203.24% | 0.22% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Alnylam Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 817 institutional investors and hedge funds held shares of Alnylam Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Capital World Investors: 16.75 M
FMR LLC: 15.31 M
VANGUARD GROUP INC: 13.06 M
BlackRock, Inc.: 9.56 M
Capital Research Global Investors: 7.15 M
REGENERON PHARMACEUTICALS, INC.: 4.44 M
99.20% of Alnylam Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 151.57 M shares in the last 24 months. This purchase volume represents approximately $46.16 B in transactions.